title: Comments on systematic review of clinical- and cost-effectiveness of candesartan and losartan in hypertension and heart failure.
authors.forename: P A
authors.initials: PA
authors.lastname: Meredith
authors.forename: S C
authors.initials: SC
authors.lastname: Jarvis
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D013777:Tetrazoles / Q000627:therapeutic use*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D001562:Benzimidazoles; D013777:Tetrazoles; D019808:Losartan